PHARMACYTE BIOTECH, INC. Proceeds from (Repayments of) Bank Overdrafts
PHARMACYTE BIOTECH, INC. (PMCB) reported Proceeds from (Repayments of) Bank Overdrafts of $0 for the 6-month period ending 2011-10-31, per its 10-Q filed 2011-12-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfBankOverdrafts · last filed 2011-12-15
- 2011-10-31: Proceeds from (Repayments of) Bank Overdrafts 6 month $0.00.
- 2010-10-31: Proceeds from (Repayments of) Bank Overdrafts 6 month $629.00.
| Period end | Proceeds from (Repayments of) Bank Overdrafts 6 month |
|---|---|
| 2011-10-31 | $0.00 10-Q · filed 2011-12-15 |
| 2010-10-31 | $629.00 10-Q · filed 2011-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |